Lucid, Inc. is revolutionizing the detection and treatment for 
skin cancer by providing dermatologists its VivaScope® confocal imagers ; an important tool that can assist them in quickly forming a clinical judgement regarding difficult skin conditions. This patented technology - used in leading medical centers around the world - provides extremely high, cellular-resolution images of a patient's skin.
The combination of the Company's unique VivaScope confocal imagers with its innovative VivaNet® telepathology system allows secure, HIPAA-compliant transfer, storage and retrieval of diagnostic images and information between dermatologists and pathologists in near real-time. Using this system allows dermatologists to transfer images and receive opinions from other medical professionals to assist them in forming clinical judgments faster than ever before possible.
Lucid's VivaScopes - the highest resolution in vivo imaging devices currently avavilable - provide a cellular-resolution "virtual biopsy" that pathologists can use to interpret and to provide diagnosis of a wide variety of malignant and non-malignant skin diseases.
